Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Penumbra (NYSE:PEN) through any online brokerage.
Other companies in Penumbra’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Penumbra has a consensus price target of $345.06.
The stock price for Penumbra (NYSE: PEN) is $320.96 last updated October 12, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Penumbra.
Penumbra does not have any upcoming earnings scheduled.
There is no upcoming split for Penumbra.
Penumbra is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.